Form 8-K - Current report:
SEC Accession No. 0001493152-25-029351
Filing Date
2025-12-29
Accepted
2025-12-29 16:00:40
Documents
14
Period of Report
2025-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39936
2 EX-4.1 ex4-1.htm EX-4.1 14534
3 GRAPHIC form8-k_001.jpg GRAPHIC 4195
  Complete submission text file 0001493152-25-029351.txt   233754

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE dyai-20251223.xsd EX-101.SCH 3008
5 XBRL LABEL FILE dyai-20251223_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE dyai-20251223_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3228
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251609043
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)